Clinical trials
Terminated Lymphoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CRISPR Therapeutics AG | 2 |
| Pfizer | 2 |
| AHS Cancer Control Alberta | 1 |
| Aegera Therapeutics | 1 |
| Astellas Pharma Inc | 1 |
| AstraZeneca | 1 |
| Celgene | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Hoffmann-La Roche | 1 |
| Kiadis Pharma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 19 |
| Leukemia | 6 |
| Lymphoma, Non-Hodgkin | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Lymphoma, B-Cell | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, T-Cell | 4 |
| Neoplasms | 4 |
| Hematologic Neoplasms | 3 |
| Lymphoma, T-Cell, Cutaneous | 2 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.